"We are convinced that work with embryonic stem cells holds enormous promise," said Harvard provost Dr. Steven Hyman.

The privately funded work is aimed at devising treatments for such ailments as diabetes, Lou Gehrig's disease, sickle-cell anemia and leukemia. Harvard is only the second American university to announce its venture into the challenging, politically charged research field.

Click here to Read the Full Article